Biology Year 1 students have visited MedImmune, the global biologics research and development arm of AstraZeneca.
MedImmune carries out innovative research and explores new ways to improve patient health. Its site at Granta Park, Great Abington, near Cambridge is one of its three major research and development facilities (the other two being in the United States). Approximately 550 staff work at the Granta Park site, mostly supporting the research and early development of the large molecule portfolio. Paul Andrew, Deputy Department Manager, explains:
“We learnt about how they make antibody therapeutics and use these antibodies in the development of new drugs. After a Health and Safety talk, we then had a tour of their laboratory facilities, and saw both scientists and state-of-the-art equipment at work.
“AstraZeneca will be opening a new research & development site on the Cambridge Biomedical Campus near Addenbrooke’s Hospital) in 2016. We are extremely fortunate to be located by the Biomedical Campus and within easy reach of Granta Park and other science parks and facilities, allowing us to develop strong links with these biomedical industries” adds Paul. “I am hoping that the visit will raise our students’ aspirations further as it is a well-equipped and pleasant place to work. MedImmune look for scientists with an appropriate PhD (e.g. biomedical) as employees.
“We are extremely grateful to MedImmune, and to John Elvin (Scientific External Liaison) for providing us with the opportunity to visit them.”